Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Comparison of 3,2-HOPO and DFO-based zirconium-89 antibody complex targeting mesothelin

Jyoti Roy, Elaine Jagoda, Falguni Basui, Olga Vasalatiy, Tim Phelps, Karen Wong, Anita Ton, Urs Hagemann, Alan Cuthbertson, Peter Choyke and Frank Lin
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1223;
Jyoti Roy
1Molecular Imaging Program National Cancer Institute Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Jagoda
1Molecular Imaging Program National Cancer Institute Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Falguni Basui
2Imaging Probe Development Center National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Vasalatiy
2Imaging Probe Development Center National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Phelps
1Molecular Imaging Program National Cancer Institute Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Wong
1Molecular Imaging Program National Cancer Institute Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anita Ton
3Molecular Imaging Program Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute. Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urs Hagemann
4Pharmaceutical Division Bayer AG Berlin Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Cuthbertson
5Thorium Conjugate Research Bayer AS Oslo Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Choyke
1Molecular Imaging Program National Cancer Institute Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Lin
1Molecular Imaging Program National Cancer Institute Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 1223

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Jyoti Roy1,
  2. Elaine Jagoda1,
  3. Falguni Basui2,
  4. Olga Vasalatiy2,
  5. Tim Phelps1,
  6. Karen Wong1,
  7. Anita Ton3,
  8. Urs Hagemann4,
  9. Alan Cuthbertson5,
  10. Peter Choyke1 and
  11. Frank Lin1
  1. 1Molecular Imaging Program National Cancer Institute Bethesda MD United States
  2. 2Imaging Probe Development Center National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda MD United States
  3. 3Molecular Imaging Program Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute. Bethesda MD United States
  4. 4Pharmaceutical Division Bayer AG Berlin Germany
  5. 5Thorium Conjugate Research Bayer AS Oslo Norway

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 20201700
Jun 20202400
Jul 20203100
Aug 20202800
Sep 20203300
Oct 20202300
Nov 20201800
Dec 20201900
Jan 20212100
Feb 20216000
Mar 20212500
Apr 20212100
May 20213500
Jun 20212300
Jul 20211400
Aug 20212100
Sep 20211400
Oct 20211200
Nov 2021700
Dec 20211500
Jan 2022800
Feb 20221300
Mar 2022900
Apr 2022800
May 20221100
Jun 2022400
Jul 2022500
Aug 2022400
Sep 2022800
Oct 2022800
Nov 2022100
Dec 2022400
Jan 2023800
Feb 2023900
Mar 2023400
Apr 2023400
May 2023600
Jun 2023400
Jul 2023400
Aug 2023200
Sep 2023700
Oct 2023100
Nov 2023600
Dec 2023800
Jan 2024800
Feb 2024700
Mar 2024400
Apr 20241000
May 2024500
Jun 2024100
Jul 2024700
Aug 20241200
Sep 20241500
Oct 2024500
Nov 2024600
Dec 2024500
Feb 2025800
Mar 2025600
Apr 2025800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of 3,2-HOPO and DFO-based zirconium-89 antibody complex targeting mesothelin
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of 3,2-HOPO and DFO-based zirconium-89 antibody complex targeting mesothelin
Jyoti Roy, Elaine Jagoda, Falguni Basui, Olga Vasalatiy, Tim Phelps, Karen Wong, Anita Ton, Urs Hagemann, Alan Cuthbertson, Peter Choyke, Frank Lin
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1223;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of 3,2-HOPO and DFO-based zirconium-89 antibody complex targeting mesothelin
Jyoti Roy, Elaine Jagoda, Falguni Basui, Olga Vasalatiy, Tim Phelps, Karen Wong, Anita Ton, Urs Hagemann, Alan Cuthbertson, Peter Choyke, Frank Lin
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1223;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Simplifying and Confirming Ketosis: A Quality Improvement Initiative in Cardiac Sarcoid Assessment
Show more

Basic Oncology & Translational (Poster Session)

  • Assessment of 18F-fluoroglucaric acid uptake in lung and brain cancer cell lines
  • Impact of ER stress and PI3K-AKT-mTOR inhibitors on NIS glycosylation and subcellular localization in thyroid cell lines
  • Estimating the minimally required tumor perfusion and receptor expression in radioligand therapy using PBPK modeling
Show more Basic Oncology & Translational (Poster Session)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire